At the conclusion of this activity, learners should be able to:


  • Summarize changes in neuromuscular disease diagnosis that have impacted the practice of neuromuscular pathology


  • Outline how genetic variants are classified as benign, pathogenic, or variants of uncertain significance


  • Identify the more common neuromuscular genes showing variants of uncertain significance


  • Compare and contrast tissue analysis modalities used in advanced muscle biopsy diagnosis
Session date: 
09/01/2021 - 12:00pm to 1:00pm EDT

Please login or register to take this course.
Room Number: 
Zoom Meeting
Speaker Name: 
Karra Jones, MD, PhD